Position in TECH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$67,487,493
+$9,292,171 QoQ
Shares Held
955,237
-14.2% QoQ
Ownership
0.609%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#37
of 592 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in TECH Over Time
Shares Held
Position Value (USD)
Derivatives in TECH
reported options exposure · as of Jun 30, 2023CallValue
$3,191,733
CallShares
39,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,144,297,346 across 338 Biotechnology names. TECH ranks #37 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in TECH
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,487,493 | 955,237 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $58,195,322 | 1,113,573 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $66,885,491 | 1,137,315 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $65,596,109 | 1,179,150 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $52,680,680 | 1,023,920 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $62,356,108 | 1,063,553 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $37,207,021 | 516,549 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $65,548,351 | 820,072 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $44,772,505 | 624,878 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $47,518,666 | 675,077 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $38,399,750 | 497,664 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $29,735,219 | 436,833 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $3,191,733 | 39,100 | Call | Defined | 2023-08-14 | |
| 2023-06-30 | $45,813,364 | 561,232 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,660,697 | 76,300 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $46,852,836 | 631,525 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $72,452,531 | 874,186 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $49,034,872 | 172,658 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $64,737,095 | 186,756 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $78,954,880 | 182,327 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $73,610,754 | 142,287 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $42,043,712 | 86,765 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $36,624,144 | 81,340 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $30,458,914 | 79,750 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $32,201,473 | 101,406 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $28,179,531 | 113,751 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $28,163,591 | 106,652 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $22,740,743 | 119,928 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||